logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Ning Lyu

sun yat -sen university
H指数:24
被引数:2,224

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study

度伐利尤单抗联合HAIC-FOLFOX，随后进行度伐利尤单抗维持治疗伴有门静脉主要侵犯的肝细胞癌：DurHope研究二期临床研究

Nature Communications
IF15.7
2026-05-180
OAAI
Junzhe Yi; Jiongliang Wang; Yimin Zhang; Xiongying Jiang; Song Chen; Jie Xu; Xintong Wu; Suixing Zhong; Qifeng Chen; Yue Hu; Yujia Song; Genjun Tan; Yunan Zhang; Jibin Li; Ming Zhao; Ning Lyu
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus

免疫检查点抑制剂和分子靶向药物联合肝动脉灌注化疗治疗肝癌合并下腔静脉和/或右心房癌栓

HEPATOLOGY INTERNATIONAL
IF6.1
2025-02-110
PRE
Zhong, Suixing; Yi, Junzhe; Chen, Song; Mo, Xiaoyan; Chen, Qifeng; Guo, Wenbo; Jiang, Xiongying; Mu, Luwen; Hu, Yue; Wang, Jiongliang; Song, Yujia; Xu, Jie; Tan, Genjun; Shi, Ming; Chen, Minshan; Lyu, Ning; Zhao, Ming
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real-world study

全身治疗失败后晚期肝细胞癌的肝动脉灌注治疗：多中心真实世界研究

HEPATOLOGY RESEARCH
IF3.4
2024-01-196
PRE
Yi, Jun-Zhe; Zhu, Zhi-Jian; Liu, Gong-Wei; Zhang, Yi-Min; Xu, Jie; Wu, Xin-Tong; Ding, Ke; Liu, Jian-Chao; Zhang, Ke-Fei; Jiang, Xiong-Ying; Chen, Qi-Feng; Hu, Yue; Chen, Song; Zhong, Sui-Xing; Wang, Jiong-Liang; Lyu, Ning; Zhao, Ming
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations

中国肝细胞癌的动脉化疗: 共识建议

HEPATOLOGY INTERNATIONAL
IF6.1
2023-10-2123
PRE
Zhao, Ming; Guo, Zhi; Zou, Ying-Hua; Li, Xiao; Yan, Zhi-Ping; Chen, Min-Shan; Fan, Wei-Jun; Li, Hai-Liang; Yang, Ji-Jin; Chen, Xiao-Ming; Xu, Lin-Feng; Zhang, Yue-Wei; Zhu, Kang-Shun; Sun, Jun-Hui; Li, Jia-Ping; Jin, Yong; Yu, Hai-Peng; Duan, Feng; Xiong, Bin; Yin, Guo-Wen; Lin, Hai-Lan; Ma, Yi-Long; Wang, Hua-Ming; Gu, Shan-Zhi; Si, Tong-Guo; Wang, Xiao-Dong; Zhao, Chang; Yu, Wen-Chang; Guo, Jian-Hai; Zhai, Jian; Huang, Yong-Hui; Wang, Wei-Yu; Lin, Hai-Feng; Gu, Yang-Kui; Chen, Jin-Zhang; Wang, Jian-Peng; Zhang, Yi-Min; Yi, Jun-Zhe; Lyu, Ning
Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trial

与索拉非尼相比，肝动脉灌注化疗治疗高肿瘤负荷和/或Vp4癌栓肝细胞癌的成本效益和预后模型: FOHAIC-1试验的事后分析

INTERNATIONAL JOURNAL OF SURGERY
IF10.1
2023-09-045
OAAI
Chen, Qi-Feng; Lyu, Ning; Wang, Xun; Jiang, Xiong-Ying; Hu, Yue; Chen, Song; Zhong, Sui-Xing; Huang, Zi-Lin; Chen, Minshan; Zhao, Ming
Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma

肿瘤源性乳酸通过调控肝癌中性粒细胞PD-L1表达抑制来伐替尼的疗效

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2021-06-2487
OAAI
Deng, Haijing; Kan, Anna; Lyu, Ning; He, Meng; Huang, Xin; Qiao, Shuang; Li, Shaolong; Lu, Wenhua; Xie, Qiankun; Chen, Huiming; Lai, Jinfa; Chen, Qifeng; Jiang, Xiongying; Liu, Shousheng; Zhang, Zhenfeng; Zhao, Ming

研究方向

暂未获取到该数据
赵
赵明
H 指数:54论文数:338被引数:1.0万
L
Luwen Mu
H 指数:13论文数:30被引数:1,057
Q
Qifeng Chen
H 指数:26论文数:125被引数:1,939
J
Jun‐Zhe Yi
H 指数:6论文数:25被引数:186
Y
Yanan Kong
H 指数:33论文数:123被引数:3,981
H
Haijing Deng
H 指数:17论文数:24被引数:1,604
J
Jinfa Lai
H 指数:8论文数:11被引数:328
S
Shaolong Li
H 指数:13论文数:39被引数:1,093
Q
Qiankun Xie
H 指数:22论文数:38被引数:1,696
M
Minshan Chen
H 指数:47论文数:289被引数:1.0万